Il y a eu 50 transactions d'initiés récentes enregistrées pour Spero Therapeutics, Inc. (SPRO), dont 26 achats et 24 ventes. Le total des achats d'initiés s'élève à $1.42M et le total des ventes d'initiés à $925.35K.
Les initiés notables ayant une activité récente comprennent Keutzer Timothy, Rajavelu Esther, Mahadevia Ankit. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — SPRO
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-06 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
18,652 |
$2.36 |
$44.02K |
742,506 |
| 2026-02-06 |
Rajavelu Esther |
See Remarks |
Vente Informative |
50,816 |
$2.36 |
$119.93K |
1,012,091 |
| 2026-02-04 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
3,471 |
$2.24 |
$7.78K |
761,158 |
| 2026-02-03 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
24,224 |
$2.14 |
$51.84K |
764,629 |
| 2026-02-02 |
Rajavelu Esther |
See Remarks |
Attribution de RSU |
498,000 |
$2.23 |
$1.11M |
498,000 |
| 2026-02-02 |
Keutzer Timothy |
Chief Operating Officer |
Attribution de RSU |
137,000 |
$2.23 |
$305.51K |
137,000 |
| 2025-11-07 |
Rajavelu Esther |
See Remarks |
Vente Informative |
40,270 |
$2.37 |
$95.44K |
869,450 |
| 2025-08-28 |
Mahadevia Ankit |
Director |
Vente Informative |
6,572 |
$1.97 |
$12.95K |
703,294 |
| 2025-08-28 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
1,695 |
$1.97 |
$3.34K |
739,744 |
| 2025-06-12 |
Thomas Frank E |
Director |
Attribution de RSU |
20,000 |
- |
- |
75,000 |
| 2025-06-12 |
Pottage John C Jr |
Director |
Attribution de RSU |
20,000 |
- |
- |
75,000 |
| 2025-06-12 |
Deshpande Milind |
Director |
Attribution de RSU |
20,000 |
- |
- |
91,454 |
| 2025-06-12 |
Vink Patrick V.j.j. |
Director |
Attribution de RSU |
20,000 |
- |
- |
75,000 |
| 2025-06-12 |
Jackson Scott Thomas |
Director |
Attribution de RSU |
20,000 |
- |
- |
75,000 |
| 2025-06-12 |
Smith Cynthia |
Director |
Attribution de RSU |
20,000 |
- |
- |
75,000 |
| 2025-06-12 |
Mahadevia Ankit |
Director |
Attribution de RSU |
20,000 |
- |
- |
709,866 |
| 2025-06-12 |
Tregoning Kathleen |
Director |
Attribution de RSU |
20,000 |
- |
- |
75,000 |
| 2025-05-02 |
Rajavelu Esther |
See Remarks |
Attribution de RSU |
185,000 |
- |
- |
909,720 |
| 2025-02-05 |
Mahadevia Ankit |
Director |
Vente Informative |
55,260 |
$0.78 |
$43.1K |
689,866 |
| 2025-02-05 |
Shukla Sath |
CEO & President |
Vente Informative |
106,408 |
$0.78 |
$83K |
1,736,883 |
| 2025-02-05 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
24,920 |
$0.78 |
$19.44K |
741,439 |
| 2025-02-05 |
Rajavelu Esther |
CFO & Cbo |
Vente Informative |
20,689 |
$0.78 |
$16.14K |
724,720 |
| 2025-02-03 |
Shukla Sath |
CEO & President |
Attribution de RSU |
751,407 |
- |
- |
1,892,216 |
| 2025-02-03 |
Keutzer Timothy |
Chief Operating Officer |
Attribution de RSU |
266,139 |
- |
- |
797,976 |
| 2025-02-03 |
Rajavelu Esther |
CFO & Cbo |
Attribution de RSU |
266,139 |
- |
- |
645,409 |
| 2024-11-08 |
Rajavelu Esther |
CFO & Cbo |
Vente Informative |
17,245 |
$1.30 |
$22.42K |
379,270 |
| 2024-11-07 |
Rajavelu Esther |
CFO & Cbo |
Vente Informative |
23,351 |
$1.31 |
$30.59K |
396,515 |
| 2024-08-27 |
Mahadevia Ankit |
Director |
Vente Informative |
5,912 |
$1.35 |
$7.98K |
759,085 |
| 2024-08-27 |
Shukla Sath |
CEO & President |
Vente Informative |
2,757 |
$1.35 |
$3.72K |
1,140,809 |
| 2024-08-27 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
2,213 |
$1.35 |
$2.99K |
531,837 |
| 2024-08-05 |
Shukla Sath |
CEO and President |
Vente Informative |
17,641 |
$1.31 |
$23.11K |
1,143,566 |
| 2024-08-02 |
Shukla Sath |
CEO and President |
Vente Informative |
14,800 |
$1.32 |
$19.54K |
1,161,207 |
| 2024-05-29 |
Thomas Frank E |
Director |
Attribution de RSU |
20,000 |
- |
- |
55,000 |
| 2024-05-29 |
Pottage John C Jr |
Director |
Attribution de RSU |
20,000 |
- |
- |
55,000 |
| 2024-05-29 |
Deshpande Milind |
Director |
Attribution de RSU |
20,000 |
- |
- |
71,454 |
| 2024-05-29 |
Vink Patrick V.j.j. |
Director |
Attribution de RSU |
20,000 |
- |
- |
55,000 |
| 2024-05-29 |
Jackson Scott Thomas |
Director |
Attribution de RSU |
20,000 |
- |
- |
55,000 |
| 2024-05-29 |
Smith Cynthia |
Director |
Attribution de RSU |
20,000 |
- |
- |
55,000 |
| 2024-05-29 |
Mahadevia Ankit |
Director |
Attribution de RSU |
20,000 |
- |
- |
764,997 |
| 2024-05-29 |
Tregoning Kathleen |
Director |
Attribution de RSU |
20,000 |
- |
- |
55,000 |
| 2024-02-05 |
Shukla Sath |
CEO and President |
Vente Informative |
45,093 |
$1.45 |
$65.38K |
1,176,007 |
| 2024-02-02 |
Joseph Tamara L |
Chief Legal Officer |
Vente Informative |
30,906 |
$1.37 |
$42.34K |
531,615 |
| 2024-02-02 |
Mahadevia Ankit |
Director |
Vente Informative |
63,795 |
$1.37 |
$87.4K |
744,997 |
| 2024-02-02 |
Shukla Sath |
CEO and President |
Vente Informative |
30,901 |
$1.37 |
$42.33K |
1,221,100 |
| 2024-02-02 |
Keutzer Timothy |
Chief Operating Officer |
Vente Informative |
30,971 |
$1.36 |
$42.12K |
534,050 |
| 2024-02-02 |
Hamed Kamal |
Chief Medical Officer |
Vente Informative |
28,075 |
$1.37 |
$38.46K |
788,117 |
| 2024-02-01 |
Joseph Tamara L |
Chief Legal Officer |
Attribution de RSU |
239,731 |
- |
- |
562,521 |
| 2024-02-01 |
Shukla Sath |
CEO and President |
Attribution de RSU |
679,501 |
- |
- |
1,252,001 |
| 2024-02-01 |
Keutzer Timothy |
Chief Operating Officer |
Attribution de RSU |
239,731 |
- |
- |
565,021 |
| 2024-02-01 |
Rajavelu Esther |
See Remarks |
Attribution de RSU |
119,866 |
- |
- |
419,866 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi